Biodesix
BDSX
27 hedge funds and large institutions have $6.04M invested in Biodesix in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 13 closing their positions.
42% more call options, than puts
Call options by funds: $78K | Put options by funds: $55K
13% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 8
1% more capital invested
Capital invested by funds: $5.99M → $6.04M (+$51.8K)
0.13% more ownership
Funds ownership: 0.47% → 0.59% (+0.13%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
25% less funds holding
Funds holding: 36 → 27 (-9)
69% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Birchview Capital
Burlington,
Vermont
|
+$1.08M |
| 2 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$729K |
| 3 |
Wells Fargo
San Francisco,
California
|
+$427K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$115K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$96.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FAM
Fred Alger Management
New York
|
-$215K |
| 2 |
CC
Chicago Capital
Chicago,
Illinois
|
-$38K |
| 3 |
E
Ergoteles
New York
|
-$36K |
| 4 |
Morgan Stanley
New York
|
-$32.6K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$22.9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TSS
26
Two Sigma Securities
New York
| – | -$22K | -658 | Closed |
|
|
HF
27
HRT Financial
New York
| – | -$18K | -550 | Closed |
|
28
Goldman Sachs
New York
| – | -$18K | -543 | Closed |
|
29
William Blair & Company
Chicago,
Illinois
| – | -$18K | -540 | Closed |
|
|
EPM
30
Equitec Proprietary Markets
Chicago,
Illinois
| – | -$11K | -345 | Closed |
|
31
UBS Group
Zurich,
Switzerland
| – | -$7.83K | -203 | -96% |
|
|
TRCT
32
Tower Research Capital (TRC)
New York
| – | -$4.09K | -106 | -98% |
|
33
Citigroup
New York
| – | -$2.24K | -58 | Closed |
|
34
Federated Hermes
Pittsburgh,
Pennsylvania
| – | -$1K | -29 | Closed |
|
|
BWL
35
Bogart Wealth LLC
Mclean,
Virginia
| – | +$347 | +9 | New |
|
36
Simplex Trading
Chicago,
Illinois
| – | +$501 | +13 | New |
|
BDSX Hedge Fund Activity: Q3 2022 in Review
27 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Biodesix (BDSX) for Q3 2022, worth a combined $6.04M — up 0.87% from $5.99M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of BDSX and 4 opened new positions — a net loss of 9 holders — while 8 trimmed existing stakes and 9 added.
The largest buyer was Birchview Capital, adding an estimated $1.08M. The largest seller was Fred Alger Management, exiting entirely with an estimated $215K sold.
- 27 institutional investors held Biodesix (BDSX) as of Q3 2022, down from 36 in Q2 2022.
- Funds reported $6.04M of Biodesix stock for Q3 2022, up 0.87% quarter-over-quarter.
- 4 funds opened new Biodesix positions in Q3 2022 and 13 closed out, a net change of -9 holders.
- The largest Biodesix buyer in Q3 2022 was Birchview Capital, an estimated $1.08M added.
- The largest Biodesix seller in Q3 2022 was Fred Alger Management, an estimated $215K sold.
Based on aggregated 13F filings for Q3 2022.